Global Opioids Drug Sales Market Report 2023

Global Opioids Drug Sales Market Report 2023

Table of Contents
1 Opioids Drug Market Overview
1.1 Opioids Drug Product Scope
1.2 Opioids Drug Segment by Type
1.2.1 Global Opioids Drug Sales by Type (2018 & 2022 & 2029)
1.2.2 Oxycodone
1.2.3 Hydromorphone
1.2.4 Codeine
1.2.5 Fentanyl
1.3 Opioids Drug Segment by Application
1.3.1 Global Opioids Drug Sales Comparison by Application (2018 & 2022 & 2029)
1.3.2 Pain Relief
1.3.3 Anesthesia
1.3.4 Others
1.4 Opioids Drug Market Estimates and Forecasts (2018-2029)
1.4.1 Global Opioids Drug Market Size in Value Growth Rate (2018-2029)
1.4.2 Global Opioids Drug Market Size in Volume Growth Rate (2018-2029)
1.4.3 Global Opioids Drug Price Trends (2018-2029)
2 Opioids Drug Estimates and Forecasts by Region
2.1 Global Opioids Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2 Global Opioids Drug Retrospective Market Scenario by Region (2018-2023)
2.2.1 Global Opioids Drug Sales Market Share by Region (2018-2023)
2.2.2 Global Opioids Drug Revenue Market Share by Region (2018-2023)
2.3 Global Opioids Drug Market Estimates and Forecasts by Region (2024-2029)
2.3.1 Global Opioids Drug Sales Estimates and Forecasts by Region (2024-2029)
2.3.2 Global Opioids Drug Revenue Forecast by Region (2024-2029)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Opioids Drug Estimates and Projections (2018-2029)
2.4.2 Europe Opioids Drug Estimates and Projections (2018-2029)
2.4.3 China Opioids Drug Estimates and Projections (2018-2029)
2.4.4 Japan Opioids Drug Estimates and Projections (2018-2029)
2.4.5 Southeast Asia Opioids Drug Estimates and Projections (2018-2029)
2.4.6 India Opioids Drug Estimates and Projections (2018-2029)
3 Global Opioids Drug Competition Landscape by Players
3.1 Global Top Opioids Drug Players by Sales (2018-2023)
3.2 Global Top Opioids Drug Players by Revenue (2018-2023)
3.3 Global Opioids Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Opioids Drug as of 2022)
3.4 Global Opioids Drug Average Price by Company (2018-2023)
3.5 Manufacturers Opioids Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Opioids Drug Market Size by Type
4.1 Global Opioids Drug Historic Market Review by Type (2018-2023)
4.1.1 Global Opioids Drug Sales by Type (2018-2023)
4.1.2 Global Opioids Drug Revenue by Type (2018-2023)
4.1.3 Global Opioids Drug Price by Type (2018-2023)
4.2 Global Opioids Drug Market Estimates and Forecasts by Type (2024-2029)
4.2.1 Global Opioids Drug Sales Forecast by Type (2024-2029)
4.2.2 Global Opioids Drug Revenue Forecast by Type (2024-2029)
4.2.3 Global Opioids Drug Price Forecast by Type (2024-2029)
5 Global Opioids Drug Market Size by Application
5.1 Global Opioids Drug Historic Market Review by Application (2018-2023)
5.1.1 Global Opioids Drug Sales by Application (2018-2023)
5.1.2 Global Opioids Drug Revenue by Application (2018-2023)
5.1.3 Global Opioids Drug Price by Application (2018-2023)
5.2 Global Opioids Drug Market Estimates and Forecasts by Application (2024-2029)
5.2.1 Global Opioids Drug Sales Forecast by Application (2024-2029)
5.2.2 Global Opioids Drug Revenue Forecast by Application (2024-2029)
5.2.3 Global Opioids Drug Price Forecast by Application (2024-2029)
6 United States Opioids Drug Market Facts & Figures
6.1 United States Opioids Drug Sales by Company
6.1.1 United States Opioids Drug Sales by Company (2018-2023)
6.1.2 United States Opioids Drug Revenue by Company (2018-2023)
6.2 United States Opioids Drug Sales Breakdown by Type
6.2.1 United States Opioids Drug Sales Breakdown by Type (2018-2023)
6.2.2 United States Opioids Drug Sales Breakdown by Type (2024-2029)
6.3 United States Opioids Drug Sales Breakdown by Application
6.3.1 United States Opioids Drug Sales Breakdown by Application (2018-2023)
6.3.2 United States Opioids Drug Sales Breakdown by Application (2024-2029)
7 Europe Opioids Drug Market Facts & Figures
7.1 Europe Opioids Drug Sales by Company
7.1.1 Europe Opioids Drug Sales by Company (2018-2023)
7.1.2 Europe Opioids Drug Revenue by Company (2018-2023)
7.2 Europe Opioids Drug Sales Breakdown by Type
7.2.1 Europe Opioids Drug Sales Breakdown by Type (2018-2023)
7.2.2 Europe Opioids Drug Sales Breakdown by Type (2024-2029)
7.3 Europe Opioids Drug Sales Breakdown by Application
7.3.1 Europe Opioids Drug Sales Breakdown by Application (2018-2023)
7.3.2 Europe Opioids Drug Sales Breakdown by Application (2024-2029)
8 China Opioids Drug Market Facts & Figures
8.1 China Opioids Drug Sales by Company
8.1.1 China Opioids Drug Sales by Company (2018-2023)
8.1.2 China Opioids Drug Revenue by Company (2018-2023)
8.2 China Opioids Drug Sales Breakdown by Type
8.2.1 China Opioids Drug Sales Breakdown by Type (2018-2023)
8.2.2 China Opioids Drug Sales Breakdown by Type (2024-2029)
8.3 China Opioids Drug Sales Breakdown by Application
8.3.1 China Opioids Drug Sales Breakdown by Application (2018-2023)
8.3.2 China Opioids Drug Sales Breakdown by Application (2024-2029)
9 Japan Opioids Drug Market Facts & Figures
9.1 Japan Opioids Drug Sales by Company
9.1.1 Japan Opioids Drug Sales by Company (2018-2023)
9.1.2 Japan Opioids Drug Revenue by Company (2018-2023)
9.2 Japan Opioids Drug Sales Breakdown by Type
9.2.1 Japan Opioids Drug Sales Breakdown by Type (2018-2023)
9.2.2 Japan Opioids Drug Sales Breakdown by Type (2024-2029)
9.3 Japan Opioids Drug Sales Breakdown by Application
9.3.1 Japan Opioids Drug Sales Breakdown by Application (2018-2023)
9.3.2 Japan Opioids Drug Sales Breakdown by Application (2024-2029)
10 Southeast Asia Opioids Drug Market Facts & Figures
10.1 Southeast Asia Opioids Drug Sales by Company
10.1.1 Southeast Asia Opioids Drug Sales by Company (2018-2023)
10.1.2 Southeast Asia Opioids Drug Revenue by Company (2018-2023)
10.2 Southeast Asia Opioids Drug Sales Breakdown by Type
10.2.1 Southeast Asia Opioids Drug Sales Breakdown by Type (2018-2023)
10.2.2 Southeast Asia Opioids Drug Sales Breakdown by Type (2024-2029)
10.3 Southeast Asia Opioids Drug Sales Breakdown by Application
10.3.1 Southeast Asia Opioids Drug Sales Breakdown by Application (2018-2023)
10.3.2 Southeast Asia Opioids Drug Sales Breakdown by Application (2024-2029)
11 India Opioids Drug Market Facts & Figures
11.1 India Opioids Drug Sales by Company
11.1.1 India Opioids Drug Sales by Company (2018-2023)
11.1.2 India Opioids Drug Revenue by Company (2018-2023)
11.2 India Opioids Drug Sales Breakdown by Type
11.2.1 India Opioids Drug Sales Breakdown by Type (2018-2023)
11.2.2 India Opioids Drug Sales Breakdown by Type (2024-2029)
11.3 India Opioids Drug Sales Breakdown by Application
11.3.1 India Opioids Drug Sales Breakdown by Application (2018-2023)
11.3.2 India Opioids Drug Sales Breakdown by Application (2024-2029)
12 Company Profiles and Key Figures in Opioids Drug Business
12.1 Teva
12.1.1 Teva Corporation Information
12.1.2 Teva Business Overview
12.1.3 Teva Opioids Drug Sales, Revenue and Gross Margin (2018-2023)
12.1.4 Teva Opioids Drug Products Offered
12.1.5 Teva Recent Development
12.2 Purdue Pharma
12.2.1 Purdue Pharma Corporation Information
12.2.2 Purdue Pharma Business Overview
12.2.3 Purdue Pharma Opioids Drug Sales, Revenue and Gross Margin (2018-2023)
12.2.4 Purdue Pharma Opioids Drug Products Offered
12.2.5 Purdue Pharma Recent Development
12.3 Mallinckrodt
12.3.1 Mallinckrodt Corporation Information
12.3.2 Mallinckrodt Business Overview
12.3.3 Mallinckrodt Opioids Drug Sales, Revenue and Gross Margin (2018-2023)
12.3.4 Mallinckrodt Opioids Drug Products Offered
12.3.5 Mallinckrodt Recent Development
12.4 Amneal Pharma
12.4.1 Amneal Pharma Corporation Information
12.4.2 Amneal Pharma Business Overview
12.4.3 Amneal Pharma Opioids Drug Sales, Revenue and Gross Margin (2018-2023)
12.4.4 Amneal Pharma Opioids Drug Products Offered
12.4.5 Amneal Pharma Recent Development
12.5 Collegium
12.5.1 Collegium Corporation Information
12.5.2 Collegium Business Overview
12.5.3 Collegium Opioids Drug Sales, Revenue and Gross Margin (2018-2023)
12.5.4 Collegium Opioids Drug Products Offered
12.5.5 Collegium Recent Development
12.6 J&J
12.6.1 J&J Corporation Information
12.6.2 J&J Business Overview
12.6.3 J&J Opioids Drug Sales, Revenue and Gross Margin (2018-2023)
12.6.4 J&J Opioids Drug Products Offered
12.6.5 J&J Recent Development
12.7 Endo
12.7.1 Endo Corporation Information
12.7.2 Endo Business Overview
12.7.3 Endo Opioids Drug Sales, Revenue and Gross Margin (2018-2023)
12.7.4 Endo Opioids Drug Products Offered
12.7.5 Endo Recent Development
12.8 Pfizer
12.8.1 Pfizer Corporation Information
12.8.2 Pfizer Business Overview
12.8.3 Pfizer Opioids Drug Sales, Revenue and Gross Margin (2018-2023)
12.8.4 Pfizer Opioids Drug Products Offered
12.8.5 Pfizer Recent Development
12.9 INSYS
12.9.1 INSYS Corporation Information
12.9.2 INSYS Business Overview
12.9.3 INSYS Opioids Drug Sales, Revenue and Gross Margin (2018-2023)
12.9.4 INSYS Opioids Drug Products Offered
12.9.5 INSYS Recent Development
12.10 Mylan
12.10.1 Mylan Corporation Information
12.10.2 Mylan Business Overview
12.10.3 Mylan Opioids Drug Sales, Revenue and Gross Margin (2018-2023)
12.10.4 Mylan Opioids Drug Products Offered
12.10.5 Mylan Recent Development
12.11 Hikma
12.11.1 Hikma Corporation Information
12.11.2 Hikma Business Overview
12.11.3 Hikma Opioids Drug Sales, Revenue and Gross Margin (2018-2023)
12.11.4 Hikma Opioids Drug Products Offered
12.11.5 Hikma Recent Development
12.12 Egalet
12.12.1 Egalet Corporation Information
12.12.2 Egalet Business Overview
12.12.3 Egalet Opioids Drug Sales, Revenue and Gross Margin (2018-2023)
12.12.4 Egalet Opioids Drug Products Offered
12.12.5 Egalet Recent Development
13 Opioids Drug Manufacturing Cost Analysis
13.1 Opioids Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Opioids Drug
13.4 Opioids Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Opioids Drug Distributors List
14.3 Opioids Drug Customers
15 Market Dynamics
15.1 Opioids Drug Industry Trends
15.2 Opioids Drug Market Drivers
15.3 Opioids Drug Market Challenges
15.4 Opioids Drug Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Opioids Drug Sales (US$ Million) Growth Rate by Type (2018 & 2022 & 2029)
Table 2. Global Opioids Drug Sales ((US$ Million)) Comparison by Application (2018 & 2022 & 2029)
Table 3. Global Opioids Drug Market Size (US$ Million) by Region: 2018 VS 2022 VS 2029
Table 4. Global Opioids Drug Sales (M Units) by Region (2018-2023)
Table 5. Global Opioids Drug Sales Market Share by Region (2018-2023)
Table 6. Global Opioids Drug Revenue (US$ Million) Market Share by Region (2018-2023))
Table 7. Global Opioids Drug Revenue Share by Region (2018-2023)
Table 8. Global Opioids Drug Sales (M Units) Forecast by Region (2024-2029)
Table 9. Global Opioids Drug Sales Market Share Forecast by Region (2024-2029)
Table 10. Global Opioids Drug Revenue (US$ Million) Forecast by Region (2024-2029)
Table 11. Global Opioids Drug Revenue Share Forecast by Region (2024-2029)
Table 12. Global Opioids Drug Sales by Company (M Units) & (2018-2023)
Table 13. Global Opioids Drug Sales Share by Company (2018-2023)
Table 14. Global Opioids Drug Revenue by Company (US$ Million) & (2018-2023)
Table 15. Global Opioids Drug Revenue Share by Company (2018-2023)
Table 16. Global Opioids Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioids Drug as of 2022)
Table 17. Global Market Opioids Drug Average Price by Company (USD/Unit) & (2018-2023)
Table 18. Manufacturers Opioids Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Opioids Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Opioids Drug Sales by Type (2018-2023) & (M Units)
Table 22. Global Opioids Drug Sales Share by Type (2018-2023)
Table 23. Global Opioids Drug Revenue by Type (2018-2023) & (US$ Million)
Table 24. Global Opioids Drug Price by Type (2018-2023) & (USD/Unit)
Table 25. Global Opioids Drug Sales by Type (2024-2029)
Table 26. Global Opioids Drug Revenue by Type (2024-2029) & (US$ Million)
Table 27. Global Opioids Drug Revenue Share by Type (2024-2029)
Table 28. Global Opioids Drug Price by Type (2024-2029) & (USD/Unit)
Table 29. Global Opioids Drug Sales by Application (2018-2023) & (M Units)
Table 30. Global Opioids Drug Sales Share by Application (2018-2023)
Table 31. Global Opioids Drug Revenue by Application (2018-2023) & (US$ Million)
Table 32. Global Opioids Drug Price by Application (2018-2023) & (USD/Unit)
Table 33. Global Opioids Drug Sales by Application (2024-2029) & (M Units)
Table 34. Global Opioids Drug Sales Share by Application (2024-2029)
Table 35. Global Opioids Drug Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Opioids Drug Revenue Share by Application (2024-2029)
Table 37. Global Opioids Drug Price by Application (2024-2029) & (USD/Unit)
Table 38. United States Opioids Drug Sales by Company (2018-2023) & (M Units)
Table 39. United States Opioids Drug Sales Market Share by Company (2018-2023)
Table 40. United States Opioids Drug Revenue by Company (2018-2023) & (US$ Million)
Table 41. United States Opioids Drug Revenue Market Share by Company (2018-2023)
Table 42. United States Opioids Drug Sales by Type (2018-2023) & (M Units)
Table 43. United States Opioids Drug Sales Market Share by Type (2018-2023)
Table 44. United States Opioids Drug Sales by Type (2024-2029) & (M Units)
Table 45. United States Opioids Drug Sales Market Share by Type (2024-2029)
Table 46. United States Opioids Drug Sales by Application (2018-2023) & (M Units)
Table 47. United States Opioids Drug Sales Market Share by Application (2018-2023)
Table 48. United States Opioids Drug Sales by Application (2024-2029) & (M Units)
Table 49. United States Opioids Drug Sales Market Share by Application (2024-2029)
Table 50. Europe Opioids Drug Sales by Company (2018-2023) & (M Units)
Table 51. Europe Opioids Drug Sales Market Share by Company (2018-2023)
Table 52. Europe Opioids Drug Revenue by Company (2018-2023) & (US$ Million)
Table 53. Europe Opioids Drug Revenue Market Share by Company (2018-2023)
Table 54. Europe Opioids Drug Sales by Type (2018-2023) & (M Units)
Table 55. Europe Opioids Drug Sales Market Share by Type (2018-2023)
Table 56. Europe Opioids Drug Sales by Type (2024-2029) & (M Units)
Table 57. Europe Opioids Drug Sales Market Share by Type (2024-2029)
Table 58. Europe Opioids Drug Sales by Application (2018-2023) & (M Units)
Table 59. Europe Opioids Drug Sales Market Share by Application (2018-2023)
Table 60. Europe Opioids Drug Sales by Application (2024-2029) & (M Units)
Table 61. Europe Opioids Drug Sales Market Share by Application (2024-2029)
Table 62. China Opioids Drug Sales by Company (2018-2023) & (M Units)
Table 63. China Opioids Drug Sales Market Share by Company (2018-2023)
Table 64. China Opioids Drug Revenue by Company (2018-2023) & (US$ Million)
Table 65. China Opioids Drug Revenue Market Share by Company (2018-2023)
Table 66. China Opioids Drug Sales by Type (2018-2023) & (M Units)
Table 67. China Opioids Drug Sales Market Share by Type (2018-2023)
Table 68. China Opioids Drug Sales by Type (2024-2029) & (M Units)
Table 69. China Opioids Drug Sales Market Share by Type (2024-2029)
Table 70. China Opioids Drug Sales by Application (2018-2023) & (M Units)
Table 71. China Opioids Drug Sales Market Share by Application (2018-2023)
Table 72. China Opioids Drug Sales by Application (2024-2029) & (M Units)
Table 73. China Opioids Drug Sales Market Share by Application (2024-2029)
Table 74. Japan Opioids Drug Sales by Company (2018-2023) & (M Units)
Table 75. Japan Opioids Drug Sales Market Share by Company (2018-2023)
Table 76. Japan Opioids Drug Revenue by Company (2018-2023) & (US$ Million)
Table 77. Japan Opioids Drug Revenue Market Share by Company (2018-2023)
Table 78. Japan Opioids Drug Sales by Type (2018-2023) & (M Units)
Table 79. Japan Opioids Drug Sales Market Share by Type (2018-2023)
Table 80. Japan Opioids Drug Sales by Type (2024-2029) & (M Units)
Table 81. Japan Opioids Drug Sales Market Share by Type (2024-2029)
Table 82. Japan Opioids Drug Sales by Application (2018-2023) & (M Units)
Table 83. Japan Opioids Drug Sales Market Share by Application (2018-2023)
Table 84. Japan Opioids Drug Sales by Application (2024-2029) & (M Units)
Table 85. Japan Opioids Drug Sales Market Share by Application (2024-2029)
Table 86. Southeast Asia Opioids Drug Sales by Company (2018-2023) & (M Units)
Table 87. Southeast Asia Opioids Drug Sales Market Share by Company (2018-2023)
Table 88. Southeast Asia Opioids Drug Revenue by Company (2018-2023) & (US$ Million)
Table 89. Southeast Asia Opioids Drug Revenue Market Share by Company (2018-2023)
Table 90. Southeast Asia Opioids Drug Sales by Type (2018-2023) & (M Units)
Table 91. Southeast Asia Opioids Drug Sales Market Share by Type (2018-2023)
Table 92. Southeast Asia Opioids Drug Sales by Type (2024-2029) & (M Units)
Table 93. Southeast Asia Opioids Drug Sales Market Share by Type (2024-2029)
Table 94. Southeast Asia Opioids Drug Sales by Application (2018-2023) & (M Units)
Table 95. Southeast Asia Opioids Drug Sales Market Share by Application (2018-2023)
Table 96. Southeast Asia Opioids Drug Sales by Application (2024-2029) & (M Units)
Table 97. Southeast Asia Opioids Drug Sales Market Share by Application (2024-2029)
Table 98. India Opioids Drug Sales by Company (2018-2023) & (M Units)
Table 99. India Opioids Drug Sales Market Share by Company (2018-2023)
Table 100. India Opioids Drug Revenue by Company (2018-2023) & (US$ Million)
Table 101. India Opioids Drug Revenue Market Share by Company (2018-2023)
Table 102. India Opioids Drug Sales by Type (2018-2023) & (M Units)
Table 103. India Opioids Drug Sales Market Share by Type (2018-2023)
Table 104. India Opioids Drug Sales by Type (2024-2029) & (M Units)
Table 105. India Opioids Drug Sales Market Share by Type (2024-2029)
Table 106. India Opioids Drug Sales by Application (2018-2023) & (M Units)
Table 107. India Opioids Drug Sales Market Share by Application (2018-2023)
Table 108. India Opioids Drug Sales by Application (2024-2029) & (M Units)
Table 109. India Opioids Drug Sales Market Share by Application (2024-2029)
Table 110. Teva Corporation Information
Table 111. Teva Description and Business Overview
Table 112. Teva Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Teva Opioids Drug Product
Table 114. Teva Recent Development
Table 115. Purdue Pharma Corporation Information
Table 116. Purdue Pharma Description and Business Overview
Table 117. Purdue Pharma Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. Purdue Pharma Opioids Drug Product
Table 119. Purdue Pharma Recent Development
Table 120. Mallinckrodt Corporation Information
Table 121. Mallinckrodt Description and Business Overview
Table 122. Mallinckrodt Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 123. Mallinckrodt Opioids Drug Product
Table 124. Mallinckrodt Recent Development
Table 125. Amneal Pharma Corporation Information
Table 126. Amneal Pharma Description and Business Overview
Table 127. Amneal Pharma Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 128. Amneal Pharma Opioids Drug Product
Table 129. Amneal Pharma Recent Development
Table 130. Collegium Corporation Information
Table 131. Collegium Description and Business Overview
Table 132. Collegium Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 133. Collegium Opioids Drug Product
Table 134. Collegium Recent Development
Table 135. J&J Corporation Information
Table 136. J&J Description and Business Overview
Table 137. J&J Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 138. J&J Opioids Drug Product
Table 139. J&J Recent Development
Table 140. Endo Corporation Information
Table 141. Endo Description and Business Overview
Table 142. Endo Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 143. Endo Opioids Drug Product
Table 144. Endo Recent Development
Table 145. Pfizer Corporation Information
Table 146. Pfizer Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 147. Pfizer Description and Business Overview
Table 148. Pfizer Opioids Drug Product
Table 149. Pfizer Recent Development
Table 150. INSYS Corporation Information
Table 151. INSYS Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 152. INSYS Description and Business Overview
Table 153. INSYS Opioids Drug Product
Table 154. INSYS Recent Development
Table 155. Mylan Corporation Information
Table 156. Mylan Description and Business Overview
Table 157. Mylan Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 158. Mylan Opioids Drug Product
Table 159. Mylan Recent Development
Table 160. Hikma Corporation Information
Table 161. Hikma Description and Business Overview
Table 162. Hikma Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 163. Hikma Opioids Drug Product
Table 164. Hikma Recent Development
Table 165. Egalet Corporation Information
Table 166. Egalet Description and Business Overview
Table 167. Egalet Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 168. Egalet Opioids Drug Product
Table 169. Egalet Recent Development
Table 170. Production Base and Market Concentration Rate of Raw Material
Table 171. Key Suppliers of Raw Materials
Table 172. Opioids Drug Distributors List
Table 173. Opioids Drug Customers List
Table 174. Opioids Drug Market Trends
Table 175. Opioids Drug Market Drivers
Table 176. Opioids Drug Market Challenges
Table 177. Opioids Drug Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Opioids Drug Product Picture
Figure 2. Global Opioids Drug Sales (US$ Million) by Type (2018 & 2022 & 2029)
Figure 3. Global Opioids Drug Sales Market Share by Type in 2022 & 2029
Figure 4. Oxycodone Product Picture
Figure 5. Hydromorphone Product Picture
Figure 6. Codeine Product Picture
Figure 7. Fentanyl Product Picture
Figure 8. Global Opioids Drug Sales (US$ Million) by Application (2018 & 2022 & 2029)
Figure 9. Global Opioids Drug Sales Market Share by Application in 2022 & 2029
Figure 10. Pain Relief Examples
Figure 11. Anesthesia Examples
Figure 12. Others Examples
Figure 13. Global Opioids Drug Sales, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Opioids Drug Sales Growth Rate (2018-2029) & (US$ Million)
Figure 15. Global Opioids Drug Sales (M Units) Growth Rate (2018-2029)
Figure 16. Global Opioids Drug Price Trends Growth Rate (2018-2029) & (USD/Unit)
Figure 17. Global Market Opioids Drug Market Size (US$ Million) by Region:2018 VS 2022 VS 2029
Figure 18. Global Opioids Drug Revenue Market Share by Region: 2018 VS 2022
Figure 19. United States Opioids Drug Revenue (US$ Million) Growth Rate (2018-2029)
Figure 20. United States Opioids Drug Sales (M Units) Growth Rate (2018-2029)
Figure 21. Europe Opioids Drug Revenue (US$ Million) Growth Rate (2018-2029)
Figure 22. Europe Opioids Drug Sales (US$ Million) Growth Rate (2018-2029)
Figure 23. China Opioids Drug Revenue (US$ Million) Growth Rate (2018-2029)
Figure 24. China Opioids Drug Sales (US$ Million) and Growth Rate (2018-2029)
Figure 25. Japan Opioids Drug Revenue (US$ Million) Growth Rate (2018-2029)
Figure 26. Japan Opioids Drug Sales (US$ Million) Growth Rate (2018-2029)
Figure 27. Southeast Asia Opioids Drug Revenue (US$ Million) Growth Rate (2018-2029)
Figure 28. Southeast Asia Opioids Drug Sales (US$ Million) Growth Rate (2018-2029)
Figure 29. India Opioids Drug Revenue (US$ Million) Growth Rate (2018-2029)
Figure 30. India Opioids Drug Sales (US$ Million) Growth Rate (2018-2029)
Figure 31. Global 5 Largest Opioids Drug Players Market Share by Revenue in Opioids Drug: 2018 & 2022
Figure 32. Opioids Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 33. Global Opioids Drug Revenue Share by Type (2018-2023)
Figure 34. Global Opioids Drug Sales Share by Type (2024-2029)
Figure 35. Global Opioids Drug Revenue Share by Type (2024-2029)
Figure 36. Global Opioids Drug Revenue Share by Application (2018-2023)
Figure 37. Global Opioids Drug Revenue Growth Rate by Application in 2018 & 2022
Figure 38. Global Opioids Drug Sales Share by Application (2024-2029)
Figure 39. Global Opioids Drug Revenue Share by Application (2024-2029)
Figure 40. Key Raw Materials Price Trend
Figure 41. Manufacturing Cost Structure of Opioids Drug
Figure 42. Manufacturing Process Analysis of Opioids Drug
Figure 43. Opioids Drug Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Pain Management Drugs Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 93

Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about The drugs for pain management. The global Pain Management Drugs market was valued at US$ 35360 million in 2023 and is anticipated to reach US$ 44550 million by 2030, witnessing a CAGR of 3.3% during The forecast period 2024-2030. The leading manufacturers in The industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13......

Global Pain Management Drugs Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131

According to our LPI (LP Information) latest study, the global Pain Management Drugs market size was valued at US$ 34590 million in 2023. With growing demand in downstream market, the Pain Management Drugs is forecast to a readjusted size of US$ 43780 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Pain Management Drugs market. Pain Management Drugs are expected to show stable growth in the future market. However......

Global Opioids Drug Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115

According to our LPI (LP Information) latest study, the global Opioids Drug market size was valued at US$ 9831.4 million in 2023. With growing demand in downstream market, the Opioids Drug is forecast to a readjusted size of US$ 8616.1 million by 2030 with a CAGR of -1.9% during review period. The research report highlights the growth potential of the global Opioids Drug market. Opioids Drug are expected to show stable growth in the future market. However, product differentiation, reduci......

Global Methadone Hydrochloride Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90

According to our LPI (LP Information) latest study, the global Methadone Hydrochloride market size was valued at US$ 63 million in 2023. With growing demand in downstream market, the Methadone Hydrochloride is forecast to a readjusted size of US$ 88 million by 2030 with a CAGR of 5.0% during review period. The research report highlights the growth potential of the global Methadone Hydrochloride market. Methadone Hydrochloride are expected to show stable growth in the future market. Howev......

Global Opioids Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 112

Market Overview of Global Opioids Drugs market: According to our latest research, the global Opioids Drugs market looks promising in the next 5 years. As of 2022, the global Opioids Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescript......

Global Opioids Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 111

According to our (Global Info Research) latest study, the global Opioids Drug market size was valued at USD 10340 million in 2023 and is forecast to a readjusted size of USD 9156.6 million by 2030 with a CAGR of -1.7% during review period. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. The......

Global Methadone Hydrochloride Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 87

According to our (Global Info Research) latest study, the global Methadone Hydrochloride market size was valued at USD 66 million in 2023 and is forecast to a readjusted size of USD 90 million by 2030 with a CAGR of 4.6% during review period. Methadone Hydrochloride is a white, crystalline material that is water-soluble. It is an opioid used to treat pain or as maintenance therapy to help with detoxification in people with opioid dependence. Market Competition is not intense, as t......

Global Pain Management Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 131

According to our (Global Info Research) latest study, the global Pain Management Drugs market size was valued at USD 36380 million in 2023 and is forecast to a readjusted size of USD 45230 million by 2030 with a CAGR of 3.2% during review period. Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about the drugs for pain management. The leading manufacturers in the industry are GSK, Pfizer and Grune......

Global Fibromyalgia Drugs Market Research Report 2023, Forecast to 2028

Published: 28-Dec-2023        Price: US 2680 Onwards        Pages: 167

The FDA has approved three drugs to treat fibromyalgia: the antidepressants duloxetine (Cymbalta) and milnacipran (Savella), plus the anti-seizure medicine pregabalin (Lyrica). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging oppo......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs